Palisade Bio, Inc.
PALI· Nasdaq
PALIPalisade Bio, Inc.
Released Aug 11, 2025, after the close
10-Q filed Aug 11, 2025, 42 days after period end · 0000950170-25-106587
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$2.78M | -$4.08M | -$3.39M | -$2.34M |
| EPS Diluted | -$0.58 |
Palisade Bio, Inc. · CIK 1357459 · Engraved from SEC EDGAR
| -$3.32 |
| -$7.93 |
| -$5.77 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
